The Commissioner for Agriculture, Prof Moses Ogbaji in a terse response to our request via a text message said: "Sincerely ...
5h
The Cool Down on MSNScientists discover mind-blowing impact of ancient tradition on our food supply today: 'Really shows the importance'"Stories and myths linked with crops are a strong part of Indigenous cultures." Scientists discover mind-blowing impact of ...
Since opening in 1987, Barzola — which has since occupied several locations across Brooklyn and Queens — has become a beloved ...
Cassava Sciences (NASDAQ:SAVA – Get Free Report)‘s stock had its “neutral” rating restated by HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $2.00 target ...
It's not just AI. Nine startups joined the so-called unicorn club around the world in February, including three in the Bay ...
The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and ...
Explore more
Cassava Technologies announced plans to build Africa’s first AI factory — a data center facility powered with NVIDIA AI ...
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...
3d
Asianet Newsable on MSNCassava Sciences Stock Drops Over 30% After Alzheimer’s Drug Fails Study – But Retail Remains HopefulShares of Texas-based biotechnology company Cassava Sciences, Inc. (SAVA) tumbled 33% on Tuesday after the company reported ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
We are disappointed that the results of REFOCUS-ALZ and RETHINK-ALZ showed no treatment benefit for patients with mild-to-moderate Alzheimer’s ...
Cassava Sciences, Inc.’s SAVA share price has dipped by 20.00%, which has investors questioning if this is right time to buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results